Curatia Medical Inc.

Based in Suzhou, China, and founded in 2015, Curatia Medical Inc. , also known as Ditai Medical Technology (Suzhou) Co. , Ltd, provides interventional medical consumables for the healthcare industry. The company develops and manufactures respiratory and cardiac devices, including FDA and CE-approved angiographic and dilatation balloon catheters.

It operates a manufacturing base in Suzhou and maintains a sales network across North America, Europe and Asia, with head office in Sunnyvale, California. In January 2026, the company closed a series A+ funding round from returning investor Hidea Investment. The company works with hospitals and clinical centers to provide disposable medical supplies. Its product portfolio includes the URSA angiographic catheter, Xcess guiding catheter, and VELA RX dilatation balloon catheter, alongside OEM manufacturing services for medical technology clients.

Its conduits have sold nearly 5 million in the United States, Germany, South Korea, Poland, and other 30 countries. The company’s revenue is generated by the sale of disposable interventional medical devices to hospitals and distributors globally. It also earns income through original equipment manufacturer (OEM) services provided to other medical device companies. The company plans to use the series A+ funding to support core product research and development, expand production lines, and facilitate market expansion.